Alfilbercept
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alfilbercept, covering 2018-07-16 to 2018-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment [Phase 4]